chang tp
number share mn
price month
sign manag enthusiasm
event eisai held scientif meet april
brief two main theme neurolog dementia-rel focu
oncolog look burgeon partnership merck driven
combin use eisai lenvima anti-cancer drug merck keytruda
brief full inform includ drug discoveri
translat research effort keio univers develop
innov leverag big data digit technolog ai present
materi impress detail time session
though brief overran allot time
manag seem confid alzheim
struck enthusiasm sens purpos character eisai
effort direct alzheim treatment howev illustr
abort joint develop aducanumab alway
clear new drug treatment develop make way
approv said eisai remain confid differ
aducanumab
transmiss pathway
characterist prove success phase trial think investor
focu turn whether result brief slate may mon
includ updat on-going negoti regul regard
signal
price rel chart measur perform
topix close
spot exchang rate
valuat metric
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
profit tax
issuanc retir stock
net chang cash
number share mn
compani mention price
